A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [14C]-labeled idasanutlin and an intravenous tracer dose of [13C]-labeled idasanutlin in a single cohort of patients with solid tumors.
Cancer Chemother Pharmacol
; 84(1): 93-103, 2019 07.
Article
em En
| MEDLINE
| ID: mdl-31062077
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirrolidinas
/
Proteínas Proto-Oncogênicas c-mdm2
/
Para-Aminobenzoatos
/
Neoplasias
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article